Xenotransplantation Organ Engineering Market

In 2026, kidney accounts for 39.1% of the xenotransplantation organ engineering market by organ type. Genetically engineered donor organs lead the technology category with 41.1% share. These segments reflect the market’s focus on functional solid-organ grafts and genetic modifications that improve immune compatibility, donor consistency, and clinical transplant readiness.